4-methoxyhonokiol has been researched along with Innate Inflammatory Response in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 7 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ashpole, NM; Ibrahim, MA; Muhammad, I; Shariat-Madar, Z; Singha, SK; Wang, M | 1 |
Bi, L; Cai, L; Guo, H; Kim, KS; Kim, KT; Ma, T; Zhang, Z; Zheng, Z | 1 |
Baek, IJ; Hong, JT; Jeong, J; Lee, BJ; Lee, JK; Lin, C; Nam, SY; Yon, JM; Yun, YW | 1 |
Cai, L; Chen, J; Conklin, DJ; Jiang, X; Kim, KH; Kim, KS; Kim, YH; Tan, Y; Wang, J; Yan, X; Zhang, Z; Zheng, Y | 1 |
Han, SB; Hong, JT; Jung, JK; Kang, JS; Kim, HS; Kim, JS; Kim, Y; Kim, YG; Kwak, YS; Lee, HK; Lee, K; Ryu, HS; Seo, SY; Yun, J | 1 |
Bae, EJ; Fei, X; Jung, JK; Ka, SO; Kim, S; Lee, Y; Park, BH; Seo, SY | 1 |
Cho, WG; Choi, DY; Choi, IS; Han, JY; Han, SB; Hong, JT; Jeong, JH; Jung, JK; Kim, HM; Kim, KH; Kim, YH; Lee, K; Lee, YJ; Nam, SY; Oh, KW; Yun, YW | 1 |
7 other study(ies) available for 4-methoxyhonokiol and Innate Inflammatory Response
Article | Year |
---|---|
4-
Topics: Animals; Biphenyl Compounds; Cardiovascular System; Disease Models, Animal; Embryo, Nonmammalian; Herbal Medicine; Inflammation; Lignans; Magnolia; Male; Oryzias; Random Allocation; Signal Transduction | 2019 |
4-O-methylhonokiol protects against diabetic cardiomyopathy in type 2 diabetic mice by activation of AMPK-mediated cardiac lipid metabolism improvement.
Topics: AMP-Activated Protein Kinases; Animals; Biphenyl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Fibrosis; Inflammation; Lignans; Lipid Metabolism; Male; Mice, Inbred C57BL; Models, Biological; Oxidative Stress | 2019 |
4-O-methylhonokiol inhibits serious embryo anomalies caused by nicotine via modulations of oxidative stress, apoptosis, and inflammation.
Topics: Animals; Apoptosis; Biphenyl Compounds; Caspase 3; Embryo Culture Techniques; Female; Glutathione Peroxidase; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation; Interleukin-1beta; Lignans; Lipid Peroxidation; Lymphoma, B-Cell; Male; Mice; Mice, Inbred ICR; Nicotine; Organogenesis; Oxidative Stress; Phospholipid Hydroperoxide Glutathione Peroxidase; Pregnancy; Rats; Rats, Sprague-Dawley; RNA, Messenger; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2014 |
The magnolia bioactive constituent 4-O-methylhonokiol protects against high-fat diet-induced obesity and systemic insulin resistance in mice.
Topics: Adipose Tissue; Adiposity; Animals; Biphenyl Compounds; Blood Glucose; Body Weight; Cholesterol; Diet, High-Fat; Fatty Liver; Feeding Behavior; Glucose Tolerance Test; Inflammation; Insulin; Insulin Resistance; Lignans; Lipid Metabolism; Magnolia; Male; Mice, Inbred C57BL; Obesity; Protective Agents; Triglycerides | 2014 |
Validation of cyclooxygenase-2 as a direct anti-inflammatory target of 4-O-methylhonokiol in zymosan-induced animal models.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biphenyl Compounds; Cyclooxygenase 2; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Delivery Systems; Female; Inflammation; Lignans; Macrophages; Mice; Mice, Inbred C57BL; Zymosan | 2015 |
The new 4-O-methylhonokiol analog GS12021 inhibits inflammation and macrophage chemotaxis: role of AMP-activated protein kinase α activation.
Topics: Adenylate Kinase; Animals; Biphenyl Compounds; Cell Line; Chemotaxis; Cyclooxygenase 2; Enzyme Activation; Inflammation; Lignans; Lipopolysaccharides; Macrophages; Mice; Morpholines; Nitric Oxide Synthase Type II | 2015 |
Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo models.
Topics: Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Analysis of Variance; Animals; Anti-Inflammatory Agents; Aspartic Acid Endopeptidases; Astrocytes; Avoidance Learning; Biphenyl Compounds; Brain; Cell Line, Transformed; Cyclooxygenase 2; Cytokines; Dinoprostone; Disease Models, Animal; Electrophoretic Mobility Shift Assay; Glial Fibrillary Acidic Protein; In Situ Nick-End Labeling; Inflammation; Lignans; Lipopolysaccharides; Male; Maze Learning; Memory Disorders; Mice; Mice, Inbred ICR; Microglia; NF-kappa B; Nitric Oxide; Peptide Fragments | 2012 |